ZOLL Medical Corporation to Participate in Conference Call Hosted by Jefferies & Company

ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that it will participate in a conference call hosted by Jefferies & Company on Friday, August 12, 2011 at 11:00 a.m. (EDT) to discuss an update on recent business issues. The call will be hosted by Jefferies Medical Devices Analyst, Raj Denhoy. ZOLL CEO, Richard A. Packer, will offer additional comments. Jefferies has arranged for a physician of their choosing to join the discussion.

To participate in the call:

11:00 AM EDT / 04:00 PM BST, Friday, August 12, 2011
U.S. Dial-in: 866-900-5944
Global Dial-in: 706-643-3801
U.K. Dial-in: +44 (0) 20 3107 0289
Conference ID#: 91510989

A replay will be available starting approximately two hours after the conclusion of the call until August 19, 2011.

REPLAY: 855-859-2056 or 404-537-3406 for international callers.
Conference ID#: 91510989

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the anticipated development of the Company's business, our belief regarding revenues, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on December 17, 2010 and updated in the Company's Quarterly Reports on Form 10-Q filed subsequently to the Form 10-K, including the Form 10-Q Quarterly Report filed on August 8, 2011. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

© 2011 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL is a registered trademark of ZOLL Medical Corporation.